A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)

Morbidity and mortality: 2007 chart book on cardiovascular, lung, and blood diseases In: National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, Chart 2007; 3-4. p. 22. Beeres S.L., Bax J.J., Dibbets-Schneider P., et al. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results. Am Heart J 2006;152:684 e11-e16. Briguori, 2006, Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina, Am Heart J, 151, 674, 10.1016/j.ahj.2005.04.033 Fuchs, 2006, Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease, Am J Cardiol, 97, 823, 10.1016/j.amjcard.2005.09.132 Losordo, 2007, Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial, Circulation, 115, 3165, 10.1161/CIRCULATIONAHA.106.687376 Perin, 2003, Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure, Circulation, 107, 2294, 10.1161/01.CIR.0000070596.30552.8B Perin, 2004, Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy, Circulation, 110, II213, 10.1161/01.CIR.0000138398.77550.62 Tse, 2006, Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis, Am J Cardiol, 98, 60, 10.1016/j.amjcard.2006.01.056 Tse, 2007, Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial), Eur Heart J, 28, 2998, 10.1093/eurheartj/ehm485 Seeger, 2007, Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction, Eur Heart J, 28, 766, 10.1093/eurheartj/ehl509 Heeschen, 2004, Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease, Circulation, 109, 1615, 10.1161/01.CIR.0000124476.32871.E3 Fuchs, 2001, Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris, Am J Cardiol, 87, 874, 10.1016/S0002-9149(00)01529-0 Cerqueira, 2002, Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association, Circulation, 105, 539, 10.1161/hc0402.102975 Friedenstein, 1974, Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method, Exp Hematol, 2, 83 Digirolamo, 1999, Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate, Br J Haematol, 107, 275, 10.1046/j.1365-2141.1999.01715.x Brooimans, 2008, Flow cytometric differential of leukocyte populations in normal bone marrow: influence of peripheral blood contamination1, Cytometry B Clin Cytom, 76B, 18, 10.1002/cyto.b.20439 Hassan, 1996, Comparison between bone marrow and G-CSF–mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection, Stem Cells, 14, 419, 10.1002/stem.140419 Steen, 2000, Characteristics of haemopoietic progenitor cells related to CD34 epitope class expression, Eur J Haematol, 64, 245, 10.1034/j.1600-0609.2000.90050.x Castro-Malaspina, 1984, Human bone marrow fibroblast colony-forming units (CFU-F), Prog Clin Biol Res, 154, 209 Gratama, 1998, Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis, Cytometry, 34, 128, 10.1002/(SICI)1097-0320(19980615)34:3<128::AID-CYTO3>3.0.CO;2-D Laughlin, 1996, CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy, Cytometry, 26, 235, 10.1002/(SICI)1097-0320(19961215)26:4<235::AID-CYTO1>3.0.CO;2-B Veyrat-Masson, 2007, Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy, Br J Haematol, 139, 312, 10.1111/j.1365-2141.2007.06786.x 2007, Human Colony-Forming Cell Assays Using MethoCult: Technical Manual, Catalog #28404 Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med, 352, 1685, 10.1056/NEJMra043430 van Ramshorst, 2009, Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial, JAMA, 301, 1997, 10.1001/jama.2009.685 Blyth, 1997, Burden and outcomes of hospitalisation for congestive heart failure, Med J Aust, 167, 67, 10.5694/j.1326-5377.1997.tb138782.x Jenkinson, 1997, Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts), Age Ageing, 26, 7, 10.1093/ageing/26.1.7 Juenger, 2002, Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables, Heart, 87, 235, 10.1136/heart.87.3.235 Assmus, 2007, Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry, Circ Res, 100, 1234, 10.1161/01.RES.0000264508.47717.6b Dimmeler, 2008, Aging and disease as modifiers of efficacy of cell therapy, Circ Res, 102, 1319, 10.1161/CIRCRESAHA.108.175943 Sasaki, 2006, Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy, Proc Natl Acad Sci U S A, 103, 14537, 10.1073/pnas.0604144103 Beausejour, 2007, Bone marrow-derived cells: the influence of aging and cellular senescence, Handb Exp Pharmacol, 67, 10.1007/978-3-540-68976-8_4 Drummond-Barbosa, 2008, Stem cells, their niches and the systemic environment: an aging network, Genetics, 180, 1787, 10.1534/genetics.108.098244